EMCURE:NSE
Emcure Pharmaceuticals Ltd
₹2,348.00
arrow_upward
+1.45%(+33.60) 1D
Nov 13, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
₹2,325.00
High
₹2,395.00
Low
₹2,315.40
Mkt. cap
447.37B
Avg. vol.
229.26K
Volume
294.54K
Dividend
0.15%
Quarterly dividend
₹0.90
Ex-dividend date
Sep 4, 2026
P/E ratio
49.29
52-wk high
₹2,429.90
52-wk low
₹1,312.30
EPS
₹47.64
No. of employees
7K
Open
₹2,325.00
High
₹2,395.00
Low
₹2,315.40
Mkt. cap
447.37B
Avg. vol.
229.26K
Volume
294.54K
Dividend
0.15%
Quarterly dividend
₹0.90
Ex-dividend date
Sep 4, 2026
P/E ratio
49.29
52-wk high
₹2,429.90
52-wk low
₹1,312.30
EPS
₹47.64
No. of employees
7K
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
Tesla Is Down 13% in 2026 While the S&P 500 Is Up. Here’s the 1 Catalyst Left This Year That Could Flip That.
Nasdaq
·
1 day ago
Chartstopper: November 13, 2026
TheStreet
·
2 hours ago
Goldman Sachs reset S&P 500 price target for 2027
Foreign Policy Journal
·
37 minutes ago
Oklo's (NYSE: OKLO) Groves Reactor Clears Final Federal Hold, Paving Way For Cancer Isotope Production Push
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees6.91K
FoundedApr 16, 1981
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteemcure.com